SuperLuckeee
Day & Swing Trader, Options/Futures & Credit Spreads
Aehr Test Systems is gaining from accelerating AI chip production, since its machines test AI chips before they leave the factory, a check that matters more as chips grow costlier and more powerful. It reported record orders, a massive backlog and a big increase in cash, and guided for revenue to potentially nearly triple next year. Buying more testing equipment usually means manufacturers are preparing to build much more AI hardware. x.com x.com
Aehr Test Systems stands to benefit because testing is a bottleneck to scaling AI chips. Testing demand is about to surge. Investors did not question its price-to-sales ratio at 120, despite the current P/S objection. x.com x.com
Aehr Test Systems is shifting from niche test provider to a required layer in scaling chip systems, and revaluation begins when the market catches up. As AI failure costs rise, testing becomes required infrastructure; Aehr reports follow-on AI processor orders and a major hyperscaler win for next-gen AI ASIC burn-in. It also tests silicon photonics as photonics replaces copper interconnects, and its wafer-level burn-in serves rising packaging complexity. x.com
Aehr Test Systems is a case of narrative running ahead of the numbers. The bull case is reasonable: a young company with a strong position in silicon carbide burn-in, genuine hyperscaler interest in AI chip burn-in and room to expand into memory and logic. But the latest quarter showed revenue down 43% year over year, with no meaningful order conversion from the AI opportunities yet. Until revenue improves and orders come through more clearly, the story stays ahead of the fundamentals. x.com
FormFactor and Aehr Test Systems are favored because testing is the one non-optional part of the AI buildout. A single bad die ruins the whole package, so pricier chips mean more testing. FormFactor's probe cards touch every wafer; Q2 set records above a $1B run rate with gross margin over 50%, HBM4 is two-thirds of DRAM revenue and a new GPU program ships this half. Aehr guides fiscal 2027 revenue up 160-200% to $130-150M on a record backlog, plus a $22M AI follow-on order. x.com
Aehr Test Systems stands to benefit from Broadcom's custom AI chip ramp because these 600W–2kW multi-die packages need burn-in testing. Broadcom said XPU shipments rose 3.5x and laid out $115B of AI revenue in FY27 and $230B in FY28 with supply secured, backed by multi-gigawatt Google, Anthropic, OpenAI and Meta deployments. Aehr won a record $41M package-level burn-in order from its lead hyperscale customer for a custom AI ASIC, with a next-gen device moving to production later this year. x.com
Aehr Test Systems is key to AI manufacturing and can even be a bottleneck, but at almost 20x revenue through 2028 at the current price, it is stratospherically priced. The risk is giant if something goes wrong for the company or for the AI ramp, and even a slowdown could be deadly at such high valuations. Tech moats are not the same as financial moats. x.com
Aehr Test Systems has become a key picks-and-shovels supplier to the AI chip boom, with its Sonoma platform the go-to system for reliability testing of high-power AI processors. On April 16, 2026, it announced a $41M follow-on order, its largest ever, from an unnamed hyperscale AI chip leader for custom AI ASIC testing, with revenue from fiscal 2027. Backlog doubled to $38.7M, second-half FY26 bookings exceed $92M, and FY26 should hit the high end of $45-50M guidance. x.com
The still-robust AI wave will inevitably drive physical AI forward, making Ouster's lidar, cameras and software stack increasingly critical. SK Hynix's strong earnings show that momentum is far from over; physical AI still has substantial runway and has not seen the hype of other AI trades. x.com
Aehr Test Systems' valuation looks ahead of its fundamentals after a strong turnaround quarter. Q4 FY2026 revenue rose 33% to $18.8 million with a return to GAAP profit, bookings hit a record $60.7 million and effective backlog topped $100.6 million. FY2027 guidance of $130-150 million implies 160-200% growth, so the post-earnings run prices in high expectations that depend on shipping FOX-XP systems on schedule without margin erosion. TRT is preferred for now. x.com x.com
Aehr Test Systems' AI wafer-level burn-in business is scaling, with a $22M follow-on order from its lead AI processor customer to expand capacity for high-volume production. That customer is already planning more capacity, and Aehr is expanding talks with other hyperscalers. The stock reached fresh all-time highs, and its recent strength looks like institutional accumulation. x.com x.com x.com
